Quarterly report pursuant to Section 13 or 15(d)

Organization (Details)

v3.19.3
Organization (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
9 Months Ended
May 24, 2019
Jan. 30, 2019
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Subsidiary, Sale of Stock [Line Items]            
Accumulated deficit     $ 180,557   $ 171,146  
Cash used in operations     14,277 $ 17,011    
Proceeds from issuance of common stock and warrants, net     16,325 3,961    
Cash     8,058 $ 12,995 $ 7,655 $ 27,813
Debt covenant, unrestricted cash     4,372      
Unrestricted cash     $ 3,686      
Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Number of shares sold (in shares)   3,067        
Price per share sold (in dollars per share)   $ 1.63        
Underwriting agreement | Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Exercise price (in dollars per share) $ 2.00          
Warrants issued (in shares) 6,667          
Number of shares sold (in shares) 6,667          
Price per share sold (in dollars per share) $ 1.5          
Proceeds from issuance of common stock and warrants, net $ 9,037